Trastuzumab Not Yet Recruiting Phase 2 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03820141Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
NCT03765983GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
NCT0336767612 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)